Cargando…
Evaluation of Cellular Immunity with ASFV Infection by Swine Leukocyte Antigen (SLA)—Peptide Tetramers
African swine fever virus (ASFV) causes acute hemorrhagic fever in domestic pigs and wild boars, resulting in incalculable economic losses to the pig industry. As the mechanism of viral infection is not clear, protective antigens have not been discovered or identified. In this study, we determined t...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617699/ https://www.ncbi.nlm.nih.gov/pubmed/34835070 http://dx.doi.org/10.3390/v13112264 |
_version_ | 1784604568554831872 |
---|---|
author | Sun, Wenqiang Zhang, He Fan, Wenhui He, Lihong Chen, Teng Zhou, Xintao Qi, Yu Sun, Lei Hu, Rongliang Luo, Tingrong Liu, Wenjun Li, Jing |
author_facet | Sun, Wenqiang Zhang, He Fan, Wenhui He, Lihong Chen, Teng Zhou, Xintao Qi, Yu Sun, Lei Hu, Rongliang Luo, Tingrong Liu, Wenjun Li, Jing |
author_sort | Sun, Wenqiang |
collection | PubMed |
description | African swine fever virus (ASFV) causes acute hemorrhagic fever in domestic pigs and wild boars, resulting in incalculable economic losses to the pig industry. As the mechanism of viral infection is not clear, protective antigens have not been discovered or identified. In this study, we determined that the p30, pp62, p72, and CD2v proteins were all involved in the T cell immune response of live pigs infected with ASFV, among which p72 and pp62 proteins were the strongest. Panoramic scanning was performed on T cell epitopes of the p72 protein, and three high-frequency positive epitopes were selected to construct a swine leukocyte antigen (SLA)-tetramer, and ASFV-specific T cells were detected. Subsequently, the specific T cell and humoral immune responses of ASFV-infected pigs and surviving pigs were compared. The results demonstrate that the specific T cellular immunity responses gradually increased during the infection and were higher than that in the surviving pigs in the late stages of infection. The same trend was observed in specific humoral immune responses, which were highest in surviving pigs. In general, our study provides key information for the exploration of ASFV-specific immune responses and the development of an ASFV vaccine. |
format | Online Article Text |
id | pubmed-8617699 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86176992021-11-27 Evaluation of Cellular Immunity with ASFV Infection by Swine Leukocyte Antigen (SLA)—Peptide Tetramers Sun, Wenqiang Zhang, He Fan, Wenhui He, Lihong Chen, Teng Zhou, Xintao Qi, Yu Sun, Lei Hu, Rongliang Luo, Tingrong Liu, Wenjun Li, Jing Viruses Article African swine fever virus (ASFV) causes acute hemorrhagic fever in domestic pigs and wild boars, resulting in incalculable economic losses to the pig industry. As the mechanism of viral infection is not clear, protective antigens have not been discovered or identified. In this study, we determined that the p30, pp62, p72, and CD2v proteins were all involved in the T cell immune response of live pigs infected with ASFV, among which p72 and pp62 proteins were the strongest. Panoramic scanning was performed on T cell epitopes of the p72 protein, and three high-frequency positive epitopes were selected to construct a swine leukocyte antigen (SLA)-tetramer, and ASFV-specific T cells were detected. Subsequently, the specific T cell and humoral immune responses of ASFV-infected pigs and surviving pigs were compared. The results demonstrate that the specific T cellular immunity responses gradually increased during the infection and were higher than that in the surviving pigs in the late stages of infection. The same trend was observed in specific humoral immune responses, which were highest in surviving pigs. In general, our study provides key information for the exploration of ASFV-specific immune responses and the development of an ASFV vaccine. MDPI 2021-11-12 /pmc/articles/PMC8617699/ /pubmed/34835070 http://dx.doi.org/10.3390/v13112264 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sun, Wenqiang Zhang, He Fan, Wenhui He, Lihong Chen, Teng Zhou, Xintao Qi, Yu Sun, Lei Hu, Rongliang Luo, Tingrong Liu, Wenjun Li, Jing Evaluation of Cellular Immunity with ASFV Infection by Swine Leukocyte Antigen (SLA)—Peptide Tetramers |
title | Evaluation of Cellular Immunity with ASFV Infection by Swine Leukocyte Antigen (SLA)—Peptide Tetramers |
title_full | Evaluation of Cellular Immunity with ASFV Infection by Swine Leukocyte Antigen (SLA)—Peptide Tetramers |
title_fullStr | Evaluation of Cellular Immunity with ASFV Infection by Swine Leukocyte Antigen (SLA)—Peptide Tetramers |
title_full_unstemmed | Evaluation of Cellular Immunity with ASFV Infection by Swine Leukocyte Antigen (SLA)—Peptide Tetramers |
title_short | Evaluation of Cellular Immunity with ASFV Infection by Swine Leukocyte Antigen (SLA)—Peptide Tetramers |
title_sort | evaluation of cellular immunity with asfv infection by swine leukocyte antigen (sla)—peptide tetramers |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617699/ https://www.ncbi.nlm.nih.gov/pubmed/34835070 http://dx.doi.org/10.3390/v13112264 |
work_keys_str_mv | AT sunwenqiang evaluationofcellularimmunitywithasfvinfectionbyswineleukocyteantigenslapeptidetetramers AT zhanghe evaluationofcellularimmunitywithasfvinfectionbyswineleukocyteantigenslapeptidetetramers AT fanwenhui evaluationofcellularimmunitywithasfvinfectionbyswineleukocyteantigenslapeptidetetramers AT helihong evaluationofcellularimmunitywithasfvinfectionbyswineleukocyteantigenslapeptidetetramers AT chenteng evaluationofcellularimmunitywithasfvinfectionbyswineleukocyteantigenslapeptidetetramers AT zhouxintao evaluationofcellularimmunitywithasfvinfectionbyswineleukocyteantigenslapeptidetetramers AT qiyu evaluationofcellularimmunitywithasfvinfectionbyswineleukocyteantigenslapeptidetetramers AT sunlei evaluationofcellularimmunitywithasfvinfectionbyswineleukocyteantigenslapeptidetetramers AT hurongliang evaluationofcellularimmunitywithasfvinfectionbyswineleukocyteantigenslapeptidetetramers AT luotingrong evaluationofcellularimmunitywithasfvinfectionbyswineleukocyteantigenslapeptidetetramers AT liuwenjun evaluationofcellularimmunitywithasfvinfectionbyswineleukocyteantigenslapeptidetetramers AT lijing evaluationofcellularimmunitywithasfvinfectionbyswineleukocyteantigenslapeptidetetramers |